Abstract
Molecular recognition has central role on the development of rational drug design. Binding affinity and interactions are two key components which aid to understand the molecular recognition in drug-receptor complex and crucial for structure-based drug design in medicinal chemistry. Herein, we report the binding affinity and the nonbonding interactions of azelaic acid and related compounds with the receptor DNA polymerase I (2KFN). Quantum mechanical calculation was employed to optimize the modified drugs using B3LYP/6-31G(d,p) level of theory. Charge distribution, dipole moment and thermodynamic properties such as electronic energy, enthalpy and free energy of these optimized drugs are also explored to evaluate how modifications impact the drug properties. Molecular docking calculation was performed to evaluate the binding affinity and nonbonding interactions between designed molecules and the receptor protein. We notice that all modified drugs are thermodynamically more stable and some of them are more chemically reactive than the unmodified drug. Promise in enhancing hydrogen bonds is found in case of fluorine-directed modifications as well as in the addition of trifluoroacetyl group. Fluorine participates in forming fluorine bonds and also stimulates alkyl, pi-alkyl interactions in some drugs. Designed drugs revealed increased binding affinity toward 2KFN. A1, A2 and A3 showed binding affinities of −8.7, −8.6 and −7.9 kcal/mol, respectively against 2KFN compared to the binding affinity −6.7 kcal/mol of the parent drug. Significant interactions observed between the drugs and Thr358 and Asp355 residues of 2KFN. Moreover, designed drugs demonstrated improved pharmacokinetic properties. This study disclosed that 9-octadecenoic acid and drugs containing trifluoroacetyl and trifluoromethyl groups are the best 2KFN inhibitors. Overall, these results can be useful for the design of new potential candidates against DNA polymerase I.
Similar content being viewed by others
Abbreviations
- AzA:
-
Azelaic acid
- DFT:
-
Density functional theory
- ADMET:
-
Absorption, distribution, metabolism, excretion, toxicity
- QM:
-
Quantum mechanics
- CASTp:
-
Computed Atlas of Surface Topography of proteins
- SDF:
-
Structure Data File
- SMILES:
-
Simplified molecular-input line-entry system
- HOMO:
-
Highest occupied molecular orbital
- LUMO:
-
Lowest unoccupied molecular orbital
- hERG:
-
Human ether-a-go-go-related gene
- BBB:
-
Blood brain barrier
References
Zhang J, Landry MP, Barone PW et al (2013) Molecular recognition using corona phase complexes made of synthetic polymers adsorbed on carbon nanotubes. Nat Nanotechnol 8:959–968. doi:10.1038/nnano.2013.236
Breiten B, Lockett MR, Sherman W et al (2013) Water networks contribute to enthalpy/entropy compensation in protein-ligand binding. J Am Chem Soc 135:15579–15584. doi:10.1021/ja4075776
Lehn JM (1992) Supramolecular chemistry: from molecular recognition towards molecular information processing and self-organization. Mater Sci Forum 91–93:100. doi:10.4028/www.scientific.net/MSF.91-93.100
Alberts B, Johnson A, Lewis J et al (2002) Protein Function. In: Molecular Biology of the Cell, 4th edn. Garland Science, New York
Persch E, Dumele O, Diederich F (2015) Molecular recognition in chemical and biological systems. Angew Chemie Int Ed. doi:10.1002/anie.201408487
Fersht AR (1987) The hydrogen bond in molecular recognition. Trends Biochem Sci 12:301–304
Zhao GJ, Han KL (2007) Early time hydrogen-bonding dynamics of photoexcited coumarin 102 in hydrogen-donating solvents: theoretical study. J Phys Chem A 111:2469–2474. doi:10.1021/jp068420j
Zhao J, Chen J, Cui Y et al (2015) A questionable excited-state double-proton transfer mechanism for 3-hydroxyisoquinoline. Phys Chem Chem Phys 17:1142–1150. doi:10.1039/c4cp04135f
Zhao G-J, Han K-L (2012) Hydrogen bonding in the electronic excited state. Acc Chem Res 45:404–413. doi:10.1021/ar200135h
Zhao J, Chen J, Liu J, Hoffmann MR (2015) Competitive excited-state single or double proton transfer mechanisms for bis-2,5-(2-benzoxazolyl)-hydroquinone and its derivatives. Phys Chem Chem Phys 17:11990–11999. doi:10.1039/c4cp05651e
Harada A, Kobayashi R, Takashima Y et al (2010) Recognition. Nat Chem 3:34–37. doi:10.1038/nchem.893
Zhao GJ, Han KL (2008) Effects of hydrogen bonding on tuning photochemistry: concerted hydrogen-bond strengthening and weakening. Chem Phys Chem 9:1842–1846. doi:10.1002/cphc.200800371
Gillis EP, Eastman KJ, Hill MD et al (2015) Applications of fluorine in medicinal chemistry. J Med Chem 58:8315–8359. doi:10.1021/acs.jmedchem.5b00258
Leroux FR, Manteau B, Vors J-P, Pazenok S (2008) Trifluoromethyl ethers–synthesis and properties of an unusual substituent. Beilstein J Org Chem 4:13. doi:10.3762/bjoc.4.13
Shah P, Westwell AD (2007) The role of fluorine in medicinal chemistry. J Enzyme Inhib Med Chem 22:527–540. doi:10.1080/14756360701425014
Fluorine in medicinal chemistry and chemical biology—Wiley Online Library. http://onlinelibrary.wiley.com/book/10.1002/9781444312096. Accessed 15 Feb 2016
Purser S, Moore PR, Swallow S, Gouverneur V (2008) Fluorine in medicinal chemistry. Chem Soc Rev 37:320–330. doi:10.1039/b610213c
Filler R, Saha R (2009) Fluorine in medicinal chemistry: a century of progress and a 60-year retrospective of selected highlights. Future Med Chem 1:777–791. doi:10.4155/fmc.09.65
Garcia-Diaz M, Bebenek K (2007) Multiple functions of DNA polymerases. CRC Crit Rev Plant Sci 26:105–122. doi:10.1080/07352680701252817
Lu Y, Liu Y, Xu Z et al (2012) Halogen bonding for rational drug design and new drug discovery. Expert Opin Drug Discov 7:375–383. doi:10.1517/17460441.2012.678829
Lopachin RM, Gavin T, Decaprio A, Barber DS (2012) Application of the hard and soft, acids and bases (HSAB) theory to toxicant–target interactions. Chem Res Toxicol 25:239–251. doi:10.1021/tx2003257
Albà M (2001) Replicative DNA polymerases. Genome Biol 2:REVIEWS3002
Lehman IR, Bessman MJ, Simms ES, Kornberg A (1958) Enzymatic synthesis of deoxyribonucleic acid. I. Preparation of substrates and partial purification of an enzyme from Escherichia coli. J Biol Chem 233:163–170
Ollis DL, Brick P, Hamlin R et al (1985) Structure of large fragment of Escherichia coli DNA polymerase I complexed with dTMP. Nature 313:762–766. doi:10.1038/313762a0
Allen WJ, Li Y, Waksman G (2010) Bacterial DNA Polymerase I. In: eLS. Wiley, Chichester. doi:10.1002/9780470015902.a0001043.pub2
Klenow H, Henningsen I (1970) Selective elimination of the exonuclease activity of the deoxyribonucleic acid polymerase from Escherichia coli B by limited proteolysis. Proc Natl Acad Sci USA 65:168–175
Derbyshire V, Grindley ND, Joyce CM (1991) The 3′-5′ exonuclease of DNA polymerase I of Escherichia coli: contribution of each amino acid at the active site to the reaction. EMBO J 10:17–24
Bernad A, Blanco L, Lázaro J et al (1989) A conserved 3′ → 5′ exonuclease active site in prokaryotic and eukaryotic DNA polymerases. Cell 59:219–228. doi:10.1016/0092-8674(89)90883-0
Bhate K, Williams HC (2013) Epidemiology of acne vulgaris. Br J Dermatol 168:474–485. doi:10.1111/bjd.12149
Williams HC, Dellavalle RP, Garner S (2012) Acne vulgaris. Lancet 379:361–372. doi:10.1016/S0140-6736(11)60321-8
Goodman G (2006) Acne and acne scarring: the case for active and early intervention. Aust Fam Physician 35:503–504
Thappa D, Adityan B, Kumari R (2009) Scoring systems in acne vulgaris. Indian J Dermatol Venereol Leprol 75:323. doi:10.4103/0378-6323.51258
James WD (2005) Clinical practice. Acne N Engl J Med 352:1463–1472. doi:10.1056/NEJMcp033487
Lolis MS, Bowe WP, Shalita AR (2009) Acne and systemic disease. Med Clin North Am 93:1161–1181. doi:10.1016/j.mcna.2009.08.008
Titus S, Hodge J (2012) Diagnosis and treatment of acne. Am Fam Physician 86:734–740
Fitton A, Goa KL (1991) Azelaic acid. A review of its pharmacological properties and therapeutic efficacy in acne and hyperpigmentary skin disorders. Drugs 41:780–798
Azelaic acid (On the skin)—National Library of Medicine—PubMed Health. http://www.ncbi.nlm.nih.gov/pubmedhealth/PMHT0009168/?report=details. Accessed 16 Feb 2016
Del Rosso JQ, Baum EW, Draelos ZD et al (2006) Azelaic acid gel 15%: clinical versatility in the treatment of rosacea. Cutis 78:6–19
Breathnach AS (1999) Azelaic acid: potential as a general antitumoural agent. Med Hypotheses 52:221–226. doi:10.1054/mehy.1997.0647
Graupe K, Cunliffe WJ, Gollnick HP, Zaumseil RP (1996) Efficacy and safety of topical azelaic acid (20 percent cream): an overview of results from European clinical trials and experimental reports. Cutis 57:20–35
Bek-Thomsen M, Lomholt HB, Kilian M (2008) Acne is not associated with yet-uncultured bacteria. J Clin Microbiol 46:3355–3360. doi:10.1128/JCM.00799-08
Leibl H, Stingl G, Pehamberger H et al (1985) Inhibition of DNA synthesis of melanoma cells by azelaic acid. J Invest Dermatol 85:417–422. doi:10.1111/1523-1747.ep12277084
Bojar RA, Holland KT, Cunliffe WJ (1991) The in vitro antimicrobial effects of zelaic acid upon Propionibacterium acnes strain P37. J Antimicrob Chemother 28:843–853
Gleeson MP, Gleeson D (2009) QM/MM calculations in drug discovery: a useful method for studying binding phenomena? J Chem Inf Model 49:670–677. doi:10.1021/ci800419j
Becke AD (1988) Density-functional exchange-energy approximation with correct asymptotic behavior. Phys Rev A 38:3098–3100. doi:10.1103/PhysRevA.38.3098
Lee C, Yang W, Parr RG (1988) Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density. Phys Rev B 37:785–789. doi:10.1103/PhysRevB.37.785
Frisch MJ, Trucks GW, Schlegel HB et al (2009) Gaussian 09, Revision A.02. Gaussian Inc Wallingford CT 34, Wallingford CT. doi:10.1159/000348293
Ray SS, Bonanno JB, Rajashankar KR et al (2002) Cocrystal structures of diaminopimelate decarboxylase: mechanism, evolution, and inhibition of an antibiotic resistance accessory factor. Structure 10:1499–1508. doi:10.1016/S0969-2126(02)00880-8
Parr RG, Yang W (1989) Density-functional theory of atoms and molecules. Int J Quantum Chem. doi:10.1002/qua.560470107
Pearson RG (1995) The HSAB principle—more quantitative aspects. Inorg Chim Acta 240:93–98. doi:10.1016/0020-1693(95)04648-8
Pearson RG (1986) Absolute electronegativity and hardness correlated with molecular orbital theory. Proc Natl Acad Sci USA 83:8440–8441. doi:10.1073/pnas.83.22.8440
Brautigam CA, Sun S, Piccirilli JA, Steitz TA (1999) Structures of normal single-stranded DNA and deoxyribo-3′-S-phosphorothiolates bound to the 3′-5′ exonucleolytic active site of DNA polymerase I from Escherichia coli. Biochemistry 38:696–704. doi:10.1021/bi981537g
Guex N, Peitsch MC (1997) SWISS-MODEL and the Swiss-PDBVIEWER: an environment for comparative protein modeling. Electrophoresis 18:2714–2723. doi:10.1002/elps.1150181505
Dundas J, Ouyang Z, Tseng J et al (2006) CASTp: computed atlas of surface topography of proteins with structural and topographical mapping of functionally annotated residues. Nucleic Acids Res 34:116–118. doi:10.1093/nar/gkl282
DeLano WL (2002) The PyMOL molecular graphics system. Schrödinger LLC wwwpymolorg Version 1.:http://www.pymol.org. doi: citeulike-article-id:240061
Trott O, Olson AJ (2010) Software news and update AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31:455–461. doi:10.1002/jcc.21334
Morris GM, Lim-Wilby M (2008) Molecular docking. Methods Mol Biol 443:365–382. doi:10.1007/978-1-59745-177-2_19
Trott O, Olson AJ (2010) AutoDock Vina. J Comput Chem 31:445–461. doi:10.1002/jcc.21334
Updated L (2013) Accelrys discovery studio 4.0 product release document
Laskowski RA, Swindells MB (2011) LigPlot+: multiple ligand-protein interaction diagrams for drug discovery. J Chem Inf Model 51:2778–2786. doi:10.1021/ci200227u
Cheng F, Li W, Zhou Y et al (2012) AdmetSAR: a comprehensive source and free tool for assessment of chemical ADMET properties. J Chem Inf Model 52:3099–3105. doi:10.1021/ci300367a
Garbett NC, Chaires JB (2012) Thermodynamic studies for drug design and screening. Expert Opin Drug Discov 7:299–314. doi:10.1517/17460441.2012.666235
Lien EJ, Guo Z-R, Li R-L, Su C-T (1982) Use of dipole moment as a parameter in drug-receptor interaction and quantitative structure-activity relationship studies. J Pharm Sci 71:641–655. doi:10.1002/jps.2600710611
Lien EJ, Guo ZR, Li RL, Su CT (1982) Use of dipole moment as a parameter in drug-receptor interaction and quantitative structure–activity relationship studies. J Pharm Sci 71:641–655
Rahman A, Hoque MM, Khan MAK et al (2016) Non-covalent interactions involving halogenated derivatives of capecitabine and thymidylate synthase: a computational approach. Springerplus 5:1–18. doi:10.1186/s40064-016-1844-y
Saleh MA, Solayman M, Hoque MM et al (2016) Inhibition of DNA topoisomerase type IIα (TOP2A) by Mitoxantrone and its halogenated derivatives: a combined density functional and molecular docking study. Biomed Res Int 2016:12
Heinz H, Suter UW (2004) Atomic charges for classical simulations of polar systems. J Phys Chem B 108:18341–18352. doi:10.1021/jp048142t
Gross KC, Seybold PG, Hadad CM (2002) Comparison of different atomic charge schemes for predicting pKa variations in substituted anilines and phenols. Int J Quantum Chem 90:445–458. doi:10.1002/qua.10108
Fukui K, Yonezawa T, Shingu H (1952) A molecular orbital theory of reactivity in aromatic hydrocarbons. J Chem Phys 20:722. doi:10.1063/1.1700523
Ayers PW, Parr RG, Pearson RG (2006) Elucidating the hard/soft acid/base principle: a perspective based on half-reactions. J Chem Phys 124:194107. doi:10.1063/1.2196882
Parr RG, Zhou Z (1993) Absolute hardness : unifying concept for identifying shells and subshells in nuclei, atoms, molecules, and metallic clusters. Acc Chem Res 26:256–258. doi:10.1021/ar00029a005
Aihara J (1999) Reduced HOMO-LUMO gap as an index of kinetic stability for polycyclic aromatic hydrocarbons. J Phys Chem A 103:7487–7495. doi:10.1021/jp990092i
Manolopoulos DE, May JC, Down SE (1991) Theoretical studies of the fullerenes: c34 to C70. Chem Phys Lett 181:105–111. doi:10.1016/0009-2614(91)90340-F
Aihara J (2000) Correlation found between the HOMO–LUMO energy separation and the chemical reactivity at the most reactive site for isolated-pentagon isomers of fullerenes. Phys Chem Chem Phys 2:3121–3125. doi:10.1039/b002601h
Gelb MH, Svaren JP, Abeles RH (1985) Fluoro ketone inhibitors of hydrolytic enzymes. Biochemistry 24:1813–1817. doi:10.1021/bi00329a001
Nair HK, Quinn DM (1993) M-alkyl alpha, alpha, alpha-trifluoroacetophenones—a new class of potent transition-state analog inhibitors of acetylcholinesterase. Bioorg Med Chem Lett 3:2619–2622. doi:10.1016/S0960-894x(01)80727-7
Veale CA, Bernstein PR, Bohnert CM et al (1997) Orally active trifluoromethyl ketone inhibitors of human leukocyte elastase. J Med Chem 40:3173–3181. doi:10.1021/jm970250z
Furuya T, Kamlet AS, Ritter T (2011) Catalysis for fluorination and trifluoromethylation. Nature 473:470–477. doi:10.1038/nature10108
McClinton MA, McClinton DA (1992) Trifluoromethylations and related reactions in organic chemistry. Tetrahedron 48:6555–6666. doi:10.1016/S0040-4020(01)80011-9
Ji Y, Brueckl T, Baxter RD et al (2011) Innate C–H trifluoromethylation of heterocycles. Proc Natl Acad Sci USA 108:14411–14415. doi:10.1073/pnas.1109059108
Lishchynskyi A, Novikov MA, Martin E et al (2013) Trifluoromethylation of aryl and heteroaryl halides with fluoroform-derived CuCF3: scope, limitations, and mechanistic features. J Org Chem 78:11126–11146. doi:10.1021/jo401423h
Sarwar MG, Ajami D, Theodorakopoulos G et al (2013) Amplified halogen bonding in a small space. J Am Chem Soc 135:13672–13675. doi:10.1021/ja407815t
Sarwar MG, Dragisic B, Salsberg LJ et al (2010) Thermodynamics of halogen bonding in solution: substituent, structural, and solvent effects. J Am Chem Soc 132:1646–1653. doi:10.1021/ja9086352
Beale TM, Chudzinski MG, Sarwar MG, Taylor MS (2013) Halogen bonding in solution: thermodynamics and applications. Chem Soc Rev. doi:10.1039/c2cs35213c
Hoque MM, Halim MA, Rahman MM et al (2013) Synthesis and structural insights of substituted 2-iodoacetanilides and 2-iodoanilines. J Mol Struct 1054–1055:367–374. doi:10.1016/j.molstruc.2013.10.011
Sarwar MG, Dragisić B, Dimitrijević E, Taylor MS (2013) Halogen bonding between anions and iodoperfluoroorganics: solution-phase thermodynamics and multidentate-receptor design. Chem A Eur J 19:2050–2058. doi:10.1002/chem.201202689
Sarwar MG, Dragisic B, Sagoo S, Taylor MS (2010) A tridentate halogen-bonding receptor for tight binding of halide anions. Angew Chem Int Ed Engl 49:1674–1677. doi:10.1002/anie.200906488
Bissantz C, Kuhn B, Stahl M (2010) A medicinal chemist’s guide to molecular interactions. J Med Chem 53:5061–5084. doi:10.1021/jm100112j
Hunter CA (2004) Quantifying intermolecular interactions: guidelines for the molecular recognition toolbox. Angew Chemie Int Ed 43:5310–5324. doi:10.1002/anie.200301739
Zhurkin VB, Tolstorukov MY, Xu F et al (2005) Sequence-dependent variability of B-DNA. DNA conform transcription. Springer, Boston, pp 18–34
Wade RC, Goodford PJ (1989) The role of hydrogen-bonds in drug binding. Prog Clin Biol Res 289:433–444
Zhao GJ, Liu JY, Zhou LC, Han KL (2007) Site-selective photoinduced electron transfer from alcoholic solvents to the chromophore facilitated by hydrogen bonding: a new fluorescence quenching mechanism. J Phys Chem B 111:8940–8945. doi:10.1021/jp0734530
Zhao G-J, Han K-L (2008) Site-specific solvation of the photoexcited protochlorophyllide a in methanol: formation of the hydrogen-bonded intermediate state induced by hydrogen-bond strengthening. Biophys J 94:38–46. doi:10.1529/biophysj.107.113738
Lee HR, Helquist SA, Kool ET, Johnson KA (2008) Importance of hydrogen bonding for efficiency and specificity of the human mitochondrial DNA polymerase. J Biol Chem 283:14402–14410. doi:10.1074/jbc.M705007200
Derbyshire V, Freemont PS, Sanderson MR et al (1988) Genetic and crystallographic studies of the 3′,5′-exonucleolytic site of DNA polymerase I. Science 240:199–201
Kuduva SS, Craig DC, Nangia A, Desiraju GR (1999) Cubanecarboxylic acids. Crystal engineering considerations and the role of C-H···O hydrogen bonds in determining O-H···O networks. J Am Chem Soc 121:1936–1944. doi:10.1021/ja981967u
Meadows ES, De Wall SL, Barbour LJ et al (2000) Structural and dynamic evidence for C − H···O hydrogen bonding in lariat ethers: implications for protein structure. J Am Chem Soc 122:3325–3335. doi:10.1021/ja9940672
Amin ML (2013) P-glycoprotein inhibition for optimal drug delivery. Drug Target Insights 2013:27–34. doi:10.4137/DTI.S12519
Sanguinetti MC, Tristani-Firouzi M (2006) hERG potassium channels and cardiac arrhythmia. Nature 440:463–469. doi:10.1038/nature04710
Acknowledgments
We are grateful to our donors who supported to build a computational platform in Bangladesh http://grc-bd.org/donate/.
Author’s Contribution
MAH, MGS and MAKK conceived the idea. MAH, MGS, MAKK and MMH designed the drugs. JS performed the quantum calculations. JS, AMK and AR performed the molecular docking, ADME calculations, data collection and draft writing. All authors read and approved the manuscript.
Funding
This research does not receive any external funding.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Authors declare that there are no competing interests regarding the publication of this paper.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Shawon, J., Khan, A.M., Rahman, A. et al. Molecular Recognition of Azelaic Acid and Related Molecules with DNA Polymerase I Investigated by Molecular Modeling Calculations. Interdiscip Sci Comput Life Sci 10, 525–537 (2018). https://doi.org/10.1007/s12539-016-0186-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12539-016-0186-3